Drug Trial Radar · NCT04641143
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
456
Actual
Start
Dec 22, 2020
Primary completion
Oct 27, 2025
Study completion Oct 27, 2025
Sponsor
- Lead sponsor
- Biohaven Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 23, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study's purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compulsive Disorder (OCD)
Conditions
- Obsessive-Compulsive Disorder
Interventions
TroriluzoleDrug
Capsules for oral administration
PlaceboDrug
Drug- matching capsules for oral administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Y-BOCS Total Score in the Baseline Y-BOCS ≥24 Stratification Cohort at Week 8 (Negative Change Indicates Symptom Improvement)Time frame: Baseline and Week 8
Locations
73 sites in 1 country. Site status is shown where the registry gives one.
Metropolitan Neuro Behavioral Institute
Chandler, Arizona
IMA Clinical Research
Phoenix, Arizona
NoeisisPharma, LLC
Phoenix, Arizona
CITrials (Clinical Innovations)
Bellflower, California
Axiom Research, LLC
Colton, California
WR-PRI, LLC (Encino)
Encino, California
Behavioral Research Specialists, LLC
Glendale, California
Pharmacology Research Institute
Los Alamitos, California
Clarity Clinical Research
Los Angeles, California
Excell Research, Inc
Oceanside, California
NRC Research Institute
Orange, California
Anderson Clinical Research
Redlands, California
Lumos Clinical Research Center, LLC
San Jose, California
California Neuroscience Research Medical Group, Inc
Sherman Oaks, California
Stanford University
Stanford, California
Collaborative Neuroscience Research
Torrance, California
Yale University / Connecticut Mental Health Center
New Haven, Connecticut
Comprehensive Psychiatric Care
Norwich, Connecticut
Boca Raton Medical Institute
Boca Raton, Florida
Advanced Clinical Research Network
Coral Gables, Florida
Research in Miami Inc
Hialeah, Florida
Accel Research Sites
Lakeland, Florida
Innovative Clinical Research, Inc.
Lauderhill, Florida
Health Care Family Rehab & Research
Miami, Florida
Central Miami Medical Institute
Miami, Florida
FIRC
Miami, Florida
Florida Research Center, Inc.
Miami, Florida
South Florida Research Phase I-IV , Inc.
Miami Springs, Florida
Behavioral Clinical Research
North Miami, Florida
Medical Research Group of Central Florida
Orange City, Florida
APG Research, LLC
Orlando, Florida
Combined Research Orlando Phase I-IV
Orlando, Florida
Omega Research Consultants
Orlando, Florida
MedBio Trials
Pembroke Pines, Florida
Stedman Clinical Trials
Tampa, Florida
Neurobehaviorial Institute
Weston, Florida
Conquest Research LLC
Winter Park, Florida
iResearch Atlanta, LLC
Decatur, Georgia
iResearch Savannah
Savannah, Georgia
Northwest Clinical Trials
Boise, Idaho
Showing 40 of 73 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.